Lisata Therapeutics Engages in Key September Investor Events

Lisata Therapeutics Engages in Key September Investor Events

BASKING RIDGE, N.J. — Lisata Therapeutics, Inc. (NASDAQ: LSTA) is excited to inform investors and interested parties about its upcoming presentations at significant industry events this September. This marks a critical opportunity for the company, which focuses on developing innovative therapies for advanced solid tumors and other serious diseases.

Participation in Annual Global Investment Conference

Lisata will present at the H.C. Wainwright 26th Annual Global Investment Conference taking place from September 9 to 11, 2024. This virtual format allows a broad audience to access presentations, with Lisata’s session available on-demand starting September 9. David J. Mazzo, PhD, the President and Chief Executive Officer of Lisata, will lead the presentation, discussing the company's innovative approaches and progress in clinical therapies.

Presence at the LSX World Congress USA

Following the global investment conference, Lisata will participate in the 2024 LSX World Congress USA on September 11-12, 2024. Unlike the virtual setting of the previous conference, this event will occur in person at the Hynes Convention Center in Boston. On September 12, Dr. Mazzo will present at 11:15 a.m. Eastern Time, providing insights into Lisata’s latest advancements and future plans.

About Lisata Therapeutics

Lisata Therapeutics is at the forefront of clinical-stage pharmaceutical development. The company is dedicated to creating transformative therapies, particularly focusing on advanced solid tumors. Its primary product candidate, certepetide, is an investigational drug that has garnered significant attention. This drug is designed to enhance the targeting and penetration of solid tumors by utilizing a novel uptake pathway, which could revolutionize the approach to cancer treatment.

Innovative Partnerships and Future Milestones

Lisata has established remarkable commercial and research partnerships that leverage its proprietary CendR Platform technology. The Company is expected to achieve numerous important milestones in the coming years, which aligns with its projected capital that will fund operations into early 2026. These developments include anticipated data releases from ongoing clinical trials that promise to bring new insights to oncology.

Investor Relations Contacts

For inquiries regarding investment opportunities, please reach out to: Lisata Therapeutics, Inc.
John Menditto
Vice President, Investor Relations and Corporate Communications
Phone: 908-842-0084
Email: jmenditto@lisata.com

Media Relations

For media-related questions, contact: ICR Westwicke
Elizabeth Coleman
Senior Associate
Phone: 203-682-4783
Email: elizabeth.coleman@westwicke.com

Frequently Asked Questions

What is Lisata Therapeutics focused on?

Lisata Therapeutics is dedicated to the development of innovative therapies for advanced solid tumors and serious diseases.

Who will present at the H.C. Wainwright conference?

Dr. David J. Mazzo, the President and CEO of Lisata, will be the key presenter during the conference.

When is the 2024 LSX World Congress USA taking place?

The LSX World Congress USA will be held from September 11 to 12, 2024, at the Hynes Convention Center in Boston.

What is certepetide?

Certepetide is Lisata's investigational drug designed to improve the effectiveness of anti-cancer therapies by targeting solid tumors more effectively.

How can I contact Lisata Therapeutics?

You can reach out to Lisata Therapeutics through their investor relations contacts or media relations representatives listed above.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.